Mycophenolic acid-eluting stent and the ABC's of stent-based immunosuppressive therapies for the prevention of restenosis.
Carter
Andrew J
AJ
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D019917:Blood Vessel Prosthesis Implantation / Q000295:instrumentation*; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D020099:Coated Materials, Biocompatible; D023903:Coronary Restenosis / Q000473:pathology / Q000517:prevention & control*; D003331:Coronary Vessels / Q000187:drug effects / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D009173:Mycophenolic Acid / Q000494:pharmacology*; D010969:Plastics; D015607:Stents; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D020099:Coated Materials, Biocompatible; D007166:Immunosuppressive Agents; D010969:Plastics; D009173:Mycophenolic Acid